Varicella Zoster Virus, technical only
Use
Varicella zoster virus (VZV) is a herpesvirus causing chickenpox (varicella) in primary infections and shingles (zoster) in reactivated infections. Detection of VZV proteins is crucial for diagnosing VZV-related diseases, especially in skin lesions, ganglia, and tissues affected by shingles or encephalitis. This test confirms active infection or reactivation by detecting VZV glycoproteins or immediate-early proteins.
Special Instructions
Not provided.
Limitations
The detection is dependent on proper specimen preparation and fixation. Specimens not fixed in 10% NBF or B plus are rejected. Turnaround times are for clinical use only and subject to change based on biopharma protocol requirements, with final times specified in study contracts.
Methodology
Immunoassay (IHC)
Biomarkers
VZV glycoprotein
Protein
Result Turnaround Time
7 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Fixed (Non-FFPE))
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Fixative should be at a 20:1 fixative to tissue ratio, 10% neutral buffered formalin (NBF) for 6-72 hours (48-72 hours PREFERRED). Specimens may be transferred to 70% ethanol for transportation after fixation.
Storage Instructions
15°C to 25°C
Causes for Rejection
Specimens must be fixed in 10% NBF or B plus. All other fixatives will be rejected.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | ≤ 72 Hours |